Skip to main content

Texas Children's Cancer Center Lands Glioma Genomics Grant

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Baylor College of Medicine and Texas Children's Cancer Center will use a new $486,000 grant to conduct genomic analyses to study genetic mutations that may cause deadly brain cancers, the Texas Children's Cancer Center said today.

The grant from the Doris Duke Charitable Foundation's Medical Research Program specifically will fund large-scale genomics studies led by Texas Children's Cancer Center's Donald Parsons that will identify and evaluate cancer-causing mutations in gliomas.

Parson, who also works at Baylor, has already conducted research that has resulted in the identification of a number of genes and pathways that contribute to tumor initiation and progression, the center said. His research identified mutations of the IDH1 and IDH2 genes as a "common and critical event" in glioma development, TCH said.

"The sponsored research will provide urgently-needed information about the biology of pediatric gliomas, which we hope to translate into improved care for our patients," Parsons said in a statement.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.